16:50 EDT Lenz Therapeutics (LENZ) files to sell 13.07M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LENZ:
- Lenz Therapeutics’ Earnings Call Highlights Positive Outlook
- Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Strong Market Position and Upcoming Product Launch
- Lenz Therapeutics price target raised to $38 from $37 at BofA
- LENZ Therapeutics: Innovative Presbyopia Treatment and Strategic Growth Reinforce Buy Rating
- Promising Outlook for LENZ Therapeutics: Buy Rating Backed by Strategic Marketing and Anticipated FDA Approval